Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion

Fertil Steril. 2013 Nov;100(5):1214-23. doi: 10.1016/j.fertnstert.2013.08.012. Epub 2013 Sep 5.

Abstract

Patients preparing to undergo gonadotoxic medical therapy or radiation therapy or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients.

Publication types

  • Practice Guideline

MeSH terms

  • Age Factors
  • Antineoplastic Agents / adverse effects*
  • Castration / adverse effects*
  • Female
  • Fertility Preservation / adverse effects
  • Fertility Preservation / methods
  • Fertility Preservation / standards*
  • Fertility* / drug effects
  • Fertility* / radiation effects
  • Gonads* / drug effects
  • Gonads* / pathology
  • Gonads* / physiopathology
  • Gonads* / radiation effects
  • Gonads* / surgery
  • Humans
  • Infertility / etiology
  • Infertility / pathology
  • Infertility / physiopathology
  • Infertility / therapy*
  • Male
  • Neoplasms / therapy*
  • Patient Care Team / standards
  • Patient Selection
  • Radiation Injuries / etiology
  • Radiation Injuries / pathology
  • Radiation Injuries / physiopathology
  • Radiation Injuries / therapy*
  • Radiotherapy / adverse effects
  • Risk Assessment
  • Risk Factors
  • Sex Factors

Substances

  • Antineoplastic Agents